Showing results (201-210 of 262) with videos related to
Sort By:
Pageof 27
The British Journal of Dermatology|April 1, 1995
Staging of metastatic melanoma by whole-body positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucoseR Böni, R A Böni, H Steinert, et al.The Journal of Investigative Dermatology|January 1, 1992
Soluble interleukin-2 receptors inhibit interleukin 2-dependent proliferation and cytotoxicity: explanation for diminished natural killer cell activity in cutaneous T-cell lymphomas in vivo?R Dummer, G Posseckert, F Nestle, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|July 16, 2008
A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-upR M Szeimies, S Ibbotson, D F Murrell, et al.Dermatology (Basel, Switzerland)|January 1, 1996
Lack of expression of dopamine D2 receptors in malignant melanoma: evidence for interaction of iodobenzofurans with melaninR Böni, H Steinert, R A Böni, et al.Blood|September 1, 1996
Lack of the t(2;5) or other mutations resulting in expression of anaplastic lymphoma kinase catalytic domain in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's diseaseG S Wood, D L Hardman, R Boni, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2008
Adjuvant low-dose interferon {alpha}2a with or without dacarbazine compared with surgery alone: a prospective-randomized phase III DeCOG trial in melanoma patients with regional lymph node metastasisC Garbe, P Radny, R Linse, et al.Oncogene|April 4, 2017
Sox2 is dispensable for primary melanoma and metastasis formationS M Schaefer, C Segalada, P F Cheng, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 28, 2014
Transient MEK inhibitor-associated retinopathy in metastatic melanomaU Urner-Bloch, M Urner, P Stieger, et al.Cancer|October 24, 2000
Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphomaL M Heinzerling, M Urbanek, J O Funk, et al.Journal of Cutaneous Pathology|February 1, 1995
Expression of bcl-2 protein and Ki-67 nuclear proliferation antigen in benign and malignant cutaneous T-cell infiltratesR Dummer, S A Michie, D Kell, et al.Pageof 27